Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
’, i.e. policies that deal with problems after they occur, rather than long-term prevention. By developing innovative simulation models that incorporate the life-course consequences of policy options, your
-
early steps in lung tumor development. You will use cutting-edge techniques including lung organoid models, single-cell transcriptomics and epigenomics, and CRISPR-based genetic perturbation. Key
-
, analysing the data, developing prognostic and simulation models and writing scientific articles. The PhD position is embedded in the research programme Operations of FEB’s Research Institute, while building
-
PhD position within the project "What's wrong? Ancient corrections in Greek papyri from Egypt" (AnCo
regular meetings of the project research group; You will participate in the training programme of the LUCAS Institute, the Leiden Graduate School of Humanities, the National Research School in Classical
-
for delta adaptation and development under uncertain changing conditions? How can we sequence measures that are made in different regions, e.g. using modelling tools? What is the timing of decisions and what
-
Apply now The Faculty of Science and the Leiden Institute of Advanced Computer Science (LIACS) are looking for: PhD Candidate, Reinforcement Learning for Sustainable Energy This position is embedded
-
involving millions of individuals. Emerging methods using population-scale microdata now allow us to construct large-scale models of social opportunity structures, offering a promising new avenue for
-
) Establish LCI models for the port call process Evaluate existing marine impact categories, and develop novel cause-effect pathways for marine impacts Establish probabilistic inventories for prospective LCA
-
Fellowship Programme (EVOLVE – EVOLVE Fellowship Programme), an initiative by six world-leading research institutes of two universities in The Netherlands (University of Groningen, Leiden University) to study
-
of contract research for both veterinary and human biomedical companies. A key focus lies in the execution of preclinical and clinical studies in viral infection models, aimed at evaluating the efficacy